-
公开(公告)号:DE59207735D1
公开(公告)日:1997-01-30
申请号:DE59207735
申请日:1992-09-21
Applicant: BASF AG
Inventor: FRIEDRICH THOMAS , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , KUENAST CHRISTOPH
-
公开(公告)号:ZA9502614B
公开(公告)日:1996-09-30
申请号:ZA9502614
申请日:1995-03-30
Applicant: BASF AG
Inventor: BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , KLINGE DAGMAR , RIECHERS HARTMUT , KROEGER BURKHARD , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , WERNET WOLFGANG , UNGER LILIANE , RASCHACK MANFRED
IPC: C07D251/26 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , A61K
CPC classification number: A61K31/505 , A61K31/506 , A61K31/53
-
公开(公告)号:CA2195243A1
公开(公告)日:1996-02-01
申请号:CA2195243
申请日:1995-07-14
Applicant: BASF AG
Inventor: HELLENDAHL BEATE , LANSKY ANNEGRET , MUNSCHAUER RAINER , BIALOJAN SIEGFRIED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE KARSTEN , DRESCHER KARLA
IPC: C07D249/08 , A61K31/41 , A61K31/435 , A61K31/4427 , A61K31/445 , A61K31/505 , A61K31/53 , A61P1/08 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , C07D249/12 , C07D249/14 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14
Abstract: The present invention relates to triazole compounds of formula (I) in which R1, R2 stand for H or different substituents, A stands for a bivalent group, B stands for a rest of the formula (a), (b) or (c) and Ar stands for optionally substituted phenyl, pyridyl, pyrimidyl or triazinyl. The compounds of the invention have a high affinity for the dopamine-D3-receptor and are therefore usable for the treatment of diseases responding to dopamine-D3-ligands.
-
公开(公告)号:CA2195241A1
公开(公告)日:1996-02-01
申请号:CA2195241
申请日:1995-07-14
Applicant: BASF AG
Inventor: HELLENDAHL BEATE , LANSKY ANNEGRET , MUNSCHAUER RAINER , BIALOJAN SIEGFRIED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE KARSTEN , DRESCHER KARLA
IPC: C07D239/26 , A61K31/505 , A61K31/506 , A61P25/16 , A61P25/24 , A61P25/26 , C07D239/38 , C07D239/46 , C07D239/56 , C07D239/60 , C07D401/00 , C07D401/12
Abstract: The use is disclosed of pyrimidine compounds having the formula (I), in which R1, R2, R3, A, B and Ar have the meanings given in the description. These compounds have a high affinity for the dopamine D3 receptor and are therefore useful for treating diseases that respond to dopamine D3 ligands.
-
公开(公告)号:AT119571T
公开(公告)日:1995-03-15
申请号:AT90917037
申请日:1990-11-22
Applicant: BASF AG
Inventor: MEYER THOMAS , FRIEDRICH THOMAS , KOERWER WOLFGANG , STRUBE KARL-HERMANN , BIALOJAN SIEGFRIED
-
公开(公告)号:CA2121134A1
公开(公告)日:1993-06-29
申请号:CA2121134
申请日:1992-09-21
Applicant: BASF AG
Inventor: FRIEDRICH THOMAS , BOLLSCHWEILER CLAUS , BIALOJAN SIEGFRIED , KUENAST CHRISTOPH
IPC: A61K35/64 , A61K38/00 , A61K38/55 , A61P7/02 , C07K14/435 , C07K14/81 , C12N15/09 , C12N15/15 , C12P21/02 , C12R1/19 , A61K38/57
Abstract: 2121134 9308282 PCTABS00021 Described is a new thrombin-inhibiting protein isolated from ticks, with a molecular weight of about 8000 Daltons and the N-terminus Leu-Asn-Val-Leu-Cys-Asn-Asn-Pro-His-Thr-Ala-Asp-Cys-Asn-Asn-Asp-Ala-Gln-Val-A_ sp. The protein is suitable for use in the treatment of illnesses.
-
公开(公告)号:MX9206055A
公开(公告)日:1993-04-01
申请号:MX9206055
申请日:1992-10-21
Applicant: BASF AG
Inventor: FRIEDRICH THOMAS , KOERWER WOLFGANG , KROEGER BRUKHARD , BIALOJAN SIEGFRIED
IPC: A61K35/64 , A61K38/00 , A61K38/55 , A61P7/02 , C07K1/14 , C07K14/435 , C07K14/81 , C12N15/09 , C12N15/15 , C12P21/02 , C07K15/00
Abstract: PCT No. PCT/EP92/02198 Sec. 371 Date Mar. 18, 1994 Sec. 102(e) Date Mar. 18, 1994 PCT Filed Sep. 23, 1992 PCT Pub. No. WO93/09231 PCT Pub. Date May 13, 1993A novel thrombin inhibitory protein from ticks with a molecular weight of about 26000 dalton and the partial amino acid sequences Val-Ala-Lys-Phe-Ala-X-Asn-Ser-Gly-Ser-Glu-Thr-Gly (SEQ ID NO: 8), His-Ala-Y-Phe-Glu (SEQ ID NO: 3), Arg-Val-Ser-Asp-Phe-Glu (SEQ ID NO: 4), Phe-Val-Tyr-Thr-Ile-Glu (SEQ ID NO: 6), where X and Y can be identical or different and each is a naturally occurring amino acid, is suitable for controlling diseases.
-
公开(公告)号:CA2093432A1
公开(公告)日:1992-04-07
申请号:CA2093432
申请日:1991-09-27
Applicant: BASF AG
Inventor: STRUBE KARL-HERMANN , BIALOJAN SIEGFRIED
IPC: A61K38/00 , A61P7/02 , C07K14/435 , C07K14/815
Abstract: 2093432 9206118 PCTABS00011 Described is a new protein, suitable for use in the treatment of illnesses, produced from Hirudo medicinalis. The protein extends the clotting time of blood, is relatively stable to heat and has a molecular weight of 25-34 KDa. Also described are the muteins of the new protein.
-
公开(公告)号:CA2195243C
公开(公告)日:2006-05-30
申请号:CA2195243
申请日:1995-07-14
Applicant: BASF AG
Inventor: HELLENDAHL BEATE , LANSKY ANNEGRET , DRESCHER KARLA , TESCHENDORF HANS-JURGEN , WICKE KARSTEN , BIALOJAN SIEGFRIED , MUNSCHAUER RAINER , UNGER LILIANE
IPC: C07D249/08 , C07D403/12 , A61K31/41 , A61K31/435 , A61K31/4427 , A61K31/445 , A61K31/505 , A61K31/53 , A61P1/08 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , C07D249/12 , C07D249/14 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/14
Abstract: The present invention relate to triazole compounds of formula (I) in which R 1, R2 stand for H or different substituents, A stands for a bivalent group, B stands for a test of the formula (a), (b) or (c) and Ar stands for optionally substituted phenyl, pyridyl, pyrimidyl or triazinyl. The compounds of the invention have a high affinity for the dopamine-D3-receptor and are therefore usable for the treatment of disease responding to dopamine-D3-ligands.
-
公开(公告)号:PT752854E
公开(公告)日:2002-02-28
申请号:PT95914301
申请日:1995-03-23
Applicant: BASF AG
Inventor: UNGER LILIANE , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , KLINGE DAGMAR , RASCHACK MANFRED , BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , RIECHERS HARTMUT , KROGER BURKHARD , WERNET WOLFGANG
IPC: A61K31/00 , A61K31/505 , A61K31/506 , C07D251/26 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I
-
-
-
-
-
-
-
-
-